Home
>
National Drug Code (NDC)
>
Erythromycin Base
Erythromycin Base - 52125-049-02 - (Erythromycin)
Drug Information of Erythromycin Base
| Product NDC: | 52125-049 |
| Proprietary Name: | Erythromycin Base |
| Non Proprietary Name: | Erythromycin |
| Active Ingredient(s): | 250 mg/1 & nbsp; Erythromycin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Erythromycin Base
| Product NDC: | 52125-049 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA061621 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130314 |
Package Information of Erythromycin Base
| Package NDC: | 52125-049-02 |
| Package Description: | 30 TABLET, FILM COATED in 1 BLISTER PACK (52125-049-02) |
NDC Information of Erythromycin Base
| NDC Code | 52125-049-02 |
| Proprietary Name | Erythromycin Base |
| Package Description | 30 TABLET, FILM COATED in 1 BLISTER PACK (52125-049-02) |
| Product NDC | 52125-049 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130314 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
